4basebio to supply DNA for pharmaceutical company's Phase I cell therapy trial

Image: Primary

Published Monday, September 28, 2026 · 9:20 AM EDT

4basebio announced an agreement to supply clinical-grade synthetic DNA for an unnamed pharmaceutical company's upcoming Phase I cell therapy trial. The agreement extends an existing customer relationship into a cell therapy program and gives 4basebio a role in producing material for a clinical-stage treatment. TriLink BioTechnologies has been selected to manufacture the trial's mRNA drug substance using the DNA supplied by 4basebio. TriLink will use its CleanCap technology, which adds a cap during mRNA production. The trial is upcoming; the announcement does not say that patients have received the therapy.

Sources

biospace.com

Published by Tech & Business, a media brand covering technology and business. This story was sourced from biospace.com and reviewed by the T&B editorial agent team.

Back to Newswire

Keep reading

Full wire

Infrastructure

Rowan raises about $1.5 billion to advance data center projects

Rowan Digital Infrastructure raised about $1.5 billion in fresh financing from lenders including Citigroup, Bloomberg reported. The Blackstone-backed data center developer is seeking to advance its growing pipeline of projects with the new financing from lenders.

Capital AI

Orakl Oncology raises $34M to expand cancer drug prediction platform

Paris-based Orakl Oncology has raised a $34M Series A co-led by Norrsken VC and Singular, bringing total funding to $50M.

Capital Infrastructure

Mount Thor raises $45 million for Apple silicon cloud infrastructure

Mount Thor announced $45 million in Seed and Series A funding to expand cloud infrastructure built on Apple silicon. CRV and Conviction co-led the Series A; Chad Byers and Offline Ventures co-led the Seed.

Capital

Nebuly raises $21 million to measure the economic value of AI agents

Nebuly raised $21 million in Series A financing to help enterprises measure the economic value of AI agents. Planven led the round for the startup, which is based in Turin and New York.

Capital Infrastructure

Gama raises €15M to move satellite solar arrays into volume production

French satellite equipment company Gama raised a €15M seed round from Transition, Planet A, Draper Associates, and Manta Ray to move its Wing solar arrays into volume production near Paris. The funding covers a production line, expanded testing, and around 60 engineering hires.

Capital AI

Axle raises $9M for investment bank meeting software and AI agents

Axle raised $9M in a round led by Eniac and Bonfire Ventures, with Teamworthy Ventures also participating, the startup announced Thursday. Its software helps investment banks arrange meetings between investors and company management, analysts and industry experts.